Study Finds Coadministration Of Quadrivalent Influenza Vaccine With RSVPreF3 Vaccine Is Well Tolerated

Infectious Disease Advisor (8/14, Nye) reports research found “three separate lots of the respiratory syncytial virus (RSV) prefusion protein F3 (PreF3) vaccine were found to have consistent immunogenicity.” Additionally, “coadministration of a single-dose quadrivalent influenza vaccine (FLU-D-QIV) with RSVPreF3 was found to be well tolerated and demonstrated immunogenic noninferiority when compared with the administration of FLU-D-QIV alone.” The findings were published in The Journal of Infectious Diseases.